Reports for MINT PHARMACEUTICALS INC
Company Name
MINT PHARMACEUTICALS INC
Totals |
||
Shortage reports |
132 |
|
Actual shortage: | 30 (23%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 0 (0%) | |
Resolved: | 102 (77%) | |
Discontinuation Reports |
29 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 29 (100%) | |
Reversed: | 0 (0%) | |
Late reports |
33 (20%) |
|
Overdue reports |
15 (50%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MINT-LOSARTAN | 50.0MG | TABLET | Resolved | 2019-01-03 | 2019-06-19 | 71074 |
MINT-LOSARTAN | 50.0MG | TABLET | Actual shortage | 2020-04-25 | 2020-04-25 | 113187 |
MINT-LOSARTAN | 100.0MG | TABLET | Resolved | 2019-01-03 | 2019-06-19 | 71066 |
MINT-LOSARTAN | 100.0MG | TABLET | Actual shortage | 2020-04-25 | 2020-04-25 | 113190 |
MINT-ESCITALOPRAM | 10MG | TABLET | Resolved | 2019-12-09 | 2020-06-09 | 100582 |
MINT-ESCITALOPRAM | 20MG | TABLET | Resolved | 2019-12-09 | 2020-06-09 | 100585 |
MINT-CLOPIDOGREL | 75MG | TABLET | Actual shortage | 2018-03-09 | 2018-03-10 | 42370 |
MINT-CLOPIDOGREL | 75MG | TABLET | Actual shortage | 2018-04-06 | 2018-04-07 | 45117 |
MINT-ZOLMITRIPTAN | 2.5MG | TABLET | Actual shortage | 2020-04-25 | 2020-04-25 | 113199 |
MINT-PAROXETINE | 10MG | TABLET | Resolved | 2018-01-09 | 2018-04-12 | 35476 |
MINT-PAROXETINE | 20MG | TABLET | Resolved | 2018-01-09 | 2018-03-03 | 35480 |
MINT-IRBESARTAN | 75MG | TABLET | Resolved | 2019-01-03 | 2021-07-12 | 71063 |
MINT-IRBESARTAN | 150MG | TABLET | Resolved | 2019-04-08 | 2021-07-12 | 80800 |
MINT-IRBESARTAN | 300MG | TABLET | Resolved | 2019-04-08 | 2021-07-12 | 80803 |
MINT-EZETIMIBE | 10MG | TABLET | Resolved | 2017-10-26 | 2017-11-11 | 27176 |
MINT-CIPROFLOX | 250MG | TABLET | Resolved | 2020-04-25 | 2022-06-06 | 113184 |
MINT-CIPROFLOX | 500MG | TABLET | Resolved | 2018-07-31 | 2020-03-21 | 57055 |
MINT-CIPROFLOX | 750MG | TABLET | Resolved | 2020-08-19 | 2022-06-06 | 122502 |
MINT-CITALOPRAM | 20MG | TABLET | Resolved | 2020-04-27 | 2020-10-10 | 113281 |
MINT-CITALOPRAM | 20MG | TABLET | Actual shortage | 2020-07-28 | 2023-01-03 | 121276 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MINT-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13540 |
MINT-RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13544 |
MINT-RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13553 |
MINT-CLOPIDOGREL | 75MG | TABLET | Discontinued | 2018-08-16 | 2018-08-17 | 58283 |
MINT-CLOPIDOGREL | 75MG | TABLET | Discontinued | 2018-08-16 | 2018-08-17 | 58286 |
MINT-METFORMIN | 500MG | TABLET | Discontinued | 2019-07-04 | 2019-07-05 | 88513 |
MINT-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95897 |
MINT-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95900 |
MINT-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95903 |
MINT-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95907 |
MINT-SOLIFENACIN | 5MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95913 |
MINT-SOLIFENACIN | 10MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95916 |
MINT-METFORMIN | 850MG | TABLET | Discontinued | 2020-03-09 | 2020-03-10 | 108292 |
MINT-FENOFIBRATE E | 145MG | TABLET | Discontinued | 2020-04-25 | 2020-04-25 | 113175 |
MINT-IRBESARTAN/HCTZ | 12.5MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143952 |
MINT-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143956 |
MINT-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143959 |
MINT-LEVOFLOXACIN | 250MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170853 |
MINT-LEVOFLOXACIN | 500MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170856 |
MINT-LEVOFLOXACIN | 750MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170859 |